WKQ-0014730

英文名稱：L-α-Glutamyl-L-alanyl-L-alanylglycyl-L-isoleucylglycyl-L-isoleucyl-L-leucyl-L-threonyl-L-valine

英文別名：L-Valine, N-[N-[N-[N-[N-[N-[N-[N-(N-L-α-glutamyl-L-alanyl)-L-alanyl]glycyl]-L-isoleucyl]glycyl]-L-isoleucyl]-L-leucyl]-L-threonyl]-;L-α-Glutamyl-L-alanyl-L-alanylglycyl-L-isoleucylglycyl-L-isoleucyl-L-leucyl-L-threonyl-L-valine;100: PN: WO2004000351 SEQID: 98 unclaimed sequence;107: PN: WO02069907 SEQID: 107 unclaimed sequence;123: PN: WO2011040978 PAGE: 49 unclaimed sequence;1281: PN: WO2006091734 PAGE: 71 claimed sequence;13: PN: JP2006236151 PAGE: 11 claimed sequence;13: PN: US20040191260 SEQID: 13 unclaimed sequence;13: PN: US20060083735 SEQID: 13 unclaimed sequence;13: PN: WO03047506 SEQID: 13 unclaimed sequence;13: PN: WO2006078059 SEQID: 13 claimed protein;14: PN: WO2020028719 SEQID: 22 claimed protein;16: PN: WO2020172472 SEQID: 160 claimed protein;173: PN: WO0178655 SEQID: 26 claimed sequence;18: PN: WO2010112962 SEQID: 25 unclaimed protein;191: PN: WO2011140284 SEQID: 228 claimed protein;1: PN: US6277956 SEQID: 1 unclaimed sequence;1: PN: WO0116320 SEQID: 1 unclaimed sequence;1: PN: WO2011140595 SEQID: 1 claimed protein;1: PN: WO2017193104 SEQID: 1 claimed protein;21: PN: WO2006120038 SEQID: 21 claimed sequence;21: PN: WO2008042814 SEQID: 20 claimed sequence;22: PN: WO2005037190 TABLE: 2 unclaimed sequence;23: PN: US6710172 SEQID: 24 unclaimed sequence;23: PN: WO2008120202 SEQID: 21 claimed sequence;24: PN: US6531451 SEQID: 24 unclaimed sequence;25: PN: WO2006082391 PAGE: 49 unclaimed sequence;26: PN: WO2011101332 SEQID: 28 claimed protein;273: PN: WO2022190007 SEQID: 273 claimed protein;27: PN: US7001999 SEQID: 27 unclaimed sequence;27: PN: WO0236146 SEQID: 27 claimed sequence;281: PN: WO2012044999 SEQID: 281 claimed sequence;285: PN: WO2019231920 SEQID: 344 claimed protein;2: PN: US20050095655 SEQID: 2 unclaimed sequence;2: PN: WO2012023033 SEQID: 2 claimed protein;2: PN: WO2015110397 SEQID: 2 claimed protein;30: PN: WO0021551 SEQID: 30 claimed sequence;31: PN: WO0050589 SEQID: 31 unclaimed sequence;32: PN: US6291430 SEQID: 68 unclaimed sequence;32: PN: WO0006598 SEQID: 33 unclaimed sequence;33: PN: US6245525 SEQID: 27 unclaimed sequence;34: PN: US20040033541 SEQID: 34 unclaimed sequence;34: PN: WO0020445 SEQID: 24 unclaimed sequence;34: PN: WO0129220 SEQID: 32 unclaimed sequence;34: PN: WO2008097817 SEQID: 34 unclaimed protein;37: PN: WO2005004907 SEQID: 37 unclaimed sequence;3: PN: EP2221060 SEQID: 3 claimed sequence;3: PN: US6326200 SEQID: 1 unclaimed sequence;3: PN: US7268219 SEQID: 3 unclaimed sequence;3: PN: US7723111 SEQID: 3 unclaimed protein;3: PN: WO02072850 SEQID: 3 unclaimed sequence;3: PN: WO2010089064 SEQID: 3 claimed sequence;40: PN: WO2010026165 SEQID: 40 unclaimed protein;41: PN: US20040023314 SEQID: 41 unclaimed sequence;41: PN: WO03100027 SEQID: 41 unclaimed sequence;43: PN: WO0013699 SEQID: 39 unclaimed sequence;4671: PN: WO2010037395 SEQID: 16634 claimed protein;46: PN: FR2842812 SEQID: 46 claimed sequence;47: PN: FR2842811 SEQID: 46 claimed sequence;480: PN: WO2022192524 SEQID: 490 claimed protein;4: PN: WO2011083296 SEQID: 2 unclaimed protein;4: PN: WO2015162204 SEQID: 4 claimed sequence;53: PN: WO0020581 SEQID: 68 unclaimed sequence;54: PN: WO0153833 SEQID: 39 unclaimed sequence;5: PN: WO2011050344 SEQID: 1 unclaimed protein;65: PN: WO0078806 SEQID: 65 unclaimed sequence;66: PN: WO0032785 SEQID: 32 unclaimed sequence;67: PN: US6716809 SEQID: 68 unclaimed sequence;68: PN: WO2004084940 SEQID: 68 unclaimed sequence;69: PN: WO2010143010 SEQID: 69 unclaimed sequence;71: PN: US20220233662 SEQID: 71 claimed protein;72: PN: US20090036653 SEQID: 73 unclaimed protein;75: PN: WO2004085635 SEQID: 78 unclaimed sequence;76: PN: WO2004035085 SEQID: 72 unclaimed sequence;78: PN: WO2012044999 SEQID: 78 unclaimed sequence;87: PN: WO2009051555 SEQID: 92 claimed protein;92: PN: WO2006138562 SEQID: 91 claimed protein;9: PN: WO2005042737 SEQID: 9 unclaimed protein;9: PN: WO2011140255 SEQID: 9 unclaimed protein;PN: WO9953061 SEQID: 27 unclaimed sequence;immunoglobulin, anti-(human MART-1/HLA-A2) (synthetic clone CLA12 L-chain);

分子式：C42H74N10O14

分子量：943.10

CAS號：156251-01-3

純度：HPLC≥98%

沸點：1358.4±65.0 °C | Condition: Press: 760 Torr

密度：1.223±0.06 g/cm3 | Condition: Temp: 20 °C Press: 760 Torr

酸系度數：3.32±0.10 | Condition: Most Acidic Temp: 25 °C

儲存條件：-20℃，干燥、避光、密封

規格：5mg10mg20mg50mg100mg500mg1g2g等應客戶需求包裝

供應單位：四川省維克奇生物科技有限公司

供應電話：028-81700200/4008005713

四川省維克奇生物科技有限公司生產中藥類標準品和天然植物有效單體，主打中藥對照品/標準品/天然植物有效單體，化學合成，抗生素三大板塊。公司推出丹參系列、龍膽系列、蟲草系列等，敬請關注！ 新批次有現貨，歡迎咨詢。